基于分子特征的胆管癌向治疗的现状和前景
Xiaowen Cui1, Teng Huang2, Tianyi Jiang3
1Department of Oncology, Eastern Hepatobiliary Surgery Hospital, The Naval Medical University, Shanghai, China.
Cancer letters
|February 9, 2025
概括
先进的胆管癌 (CCA) 治疗正在通过向疗法和免疫疗法发展. 酸酶张力同位素 (PTEN) 作为预测CCA患者预后和指导治疗的生物标志物具有前景.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 胆管癌 (CCA) 由于诊断迟到和结果差,造成了重大的公共卫生挑战.
- 最近的进展改善了对CCA的理解和管理,特别是在高级阶段.
研究的目的:
- 审查针对高级CCA的向治疗的进展,重点关注亚洲人群.
- 详细说明酸酶张力同类素 (PTEN) 作为预后生物标志物和治疗点的作用.
- 讨论对向药物的耐药性机制和CCA精准医学的未来.
主要方法:
- 关于先进的CCA治疗的最新研究的文献综述.
- 对针对性疗法和免疫疗法的数据分析.
- 专注于基因突变和生物标志物,如PTEN.
主要成果:
- 结合吉姆西塔和西斯 (GP) 化疗与免疫治疗,是第一线治疗的新标准.
- 大约40%的晚期CCA患者具有可用于二线分子治疗的可向突变.
- PTEN被确定为一线和二线治疗的新生物标志物,具有预后影响.
结论:
- 向疗法,特别是与免疫疗法结合使用,在治疗晚期CCA方面取得了重大进展.
- 在CCA中,PTEN具有作为治疗选择和预后预测的关键生物标志物的潜力.
- 对抗性机制的进一步研究对于开发下一代向疗法和推进CCA精准医学至关重要.
更多相关视频
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
647
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K